Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

44
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
44
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

498
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
498
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

3.8K
3.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer.

Frontiers in immunology·2026
Same author

Design of an infrared/laser dual-band common-aperture optical system based on harmonic diffraction.

Applied optics·2026
Same author

Stage-Specific Effects of Climatic Variation on Rice Yield and Nitrogen Use Efficiency for Identifying Adaptive Genotypes Based on Variable Selection Method.

Plants (Basel, Switzerland)·2026
Same author

Variational Bayesian Multi-Kernel Adaptive Deep Fusion for Microbe-Related Drug Prediction.

Journal of chemical information and modeling·2026
Same author

A partner protein helps OsNRAMP3 win a novel function to transport Fe<sup>2+</sup> in rice.

Journal of integrative plant biology·2025
Same author

Durable complete response to PD-1 inhibitor in vesical calculus-associated squamous cell carcinoma: a case report.

Frontiers in immunology·2025

相关实验视频

Updated: Jul 1, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.2K

内核贝叶斯非线性矩阵因子化基于人类-病毒蛋白质-蛋白质相互作用预测的变异推理.

Yingjun Ma1, Yongbiao Zhao2, Yuanyuan Ma3,4

  • 1School of Mathematics and Statistics, Xiamen University of Technology, Xiamen, China.

Scientific reports
|March 7, 2024
PubMed
概括

这项研究介绍了VKBNMF,这是一种用于预测人-病毒蛋白-蛋白相互作用 (PPI) 的新型计算模型. 通过提高识别这些关键相互作用的准确性和效率,VKBNMF增强了抗病毒药物发现.

关键词:
自动排名确定自动排名确定.贝叶斯矩阵分解因子化人类蛋白质是人类蛋白质.变量推理推理是不同的.病毒蛋白质是病毒中的蛋白质.

更多相关视频

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

相关实验视频

Last Updated: Jul 1, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.2K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.0K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

科学领域:

  • 计算生物学是一种计算生物学.
  • 病毒学 病毒学
  • 药物发现 药物发现

背景情况:

  • 人类病毒蛋白蛋白相互作用 (PPI) 对于理解病毒感染机制和开发抗病毒疗法至关重要.
  • 现有的PPI预测计算模型经常受到手动超参数调整的影响,从而限制了效率和通用性.

研究的目的:

  • 开发一个高效和准确的计算模型来预测人类病毒PPI.
  • 通过结合自动参数搜索和排名确定来解决现有模型的局限性.

主要方法:

  • 提出了一个内核贝叶斯逻辑矩阵分解模型与自动等级确定 (VKBNMF).
  • 集成辅助信息和贝叶斯框架,用于潜在变量的先验概率.
  • 实现了一个可变推理框架,以实现高效的计算.

主要成果:

  • 在对PPI预测的基准数据集上,VKBNMF实现了高平均AUPR值 (0.9101-0.9517).
  • 在预测涉及新人类或病毒蛋白质的相互作用方面表现出更高的命中率.
  • 案例研究证实了VKBNMF作为预测工具的有效性.

结论:

  • VKBNMF提供了一种有效和准确的方法来预测人类病毒的PPI.
  • 该模型的自动参数搜索和排名确定提高了其计算效率和概括能力.
  • VKBNMF通过改进PPI预测,显示了推动抗病毒药物开发的前景.